+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 45Years
FEMALE
ID07842341

Evaluating Virtual Social Support and Medication Management with Remote Blood Pressure Monitoring for Pregnant Women with Hypertension

Led by Texas Southern University · Updated on 2026-10-14

158

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether adding support from Community Health Workers or Social Workers for non-medical health-related needs NMHRN and clinician-led Medication Therapy Management MTM to remote blood pressure monitoring improves health outcomes for pregnant women with chronic or gestational hypertension. This study involves pregnant women aged 18 to 45 who have high blood pressure before or during pregnancy. The trial aims to assess blood pressure control, maternal outcomes, feasibility, and participant satisfaction. All participants will use a TelliHealth BP01 remote blood pressure monitoring kit and the TSU MH Rx app to check their blood pressure at home at least three times weekly until 14 weeks after giving birth. They will complete various self-assessments about social needs, depression, anxiety, and pregnancy care experiences at specific pregnancy stages and postpartum. Participants in the intervention group will receive additional virtual support sessions from Community Health Workers or Social Workers, as well as regular clinician-led medication management sessions every four weeks focusing on medication, self-care, adherence, and risk reduction. During the study, participants will complete surveys and blood pressure monitoring regularly. Alerts will be sent automatically for abnormal readings or concerning mental health scores, prompting appropriate follow-up. The study measures include changes in systolic blood pressure up to 14 weeks postpartum, recruitment and retention rates, technical reliability of devices and apps, participant satisfaction, and scores from mental health and prenatal care experience surveys. The total participation can last up to about 54 weeks from enrollment through postpartum follow-up.

CONDITIONS

Brief Title

MH-Rx Study (Baby on Board: Check-in on You, Your Medication, & Your Blood Pressure)

Research Team

V

Veronica Ajewole-Mwema, PharmD, BCOP

M

Mark Ibarra-Garza, B.Sc, CCRP

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here